Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies

Hepatitis B virus (HBV) chronically infects over 250 million people worldwide and causes nearly 1 million deaths per year due to cirrhosis and liver cancer. Approved treatments for chronic infection include injectable type-I interferons and nucleos(t)ide reverse transcriptase inhibitors. A small min...

Descripción completa

Detalles Bibliográficos
Autores principales: Novotny, Laura A., Evans, John Grayson, Su, Lishan, Guo, Haitao, Meissner, Eric G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230240/
https://www.ncbi.nlm.nih.gov/pubmed/34207487
http://dx.doi.org/10.3390/v13061090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230240/
https://www.ncbi.nlm.nih.gov/pubmed/34207487
http://dx.doi.org/10.3390/v13061090

Ejemplares similares